ePORE Therapy Logo
  • About Mirai
  • Technology
    • What is Electroporation?
    • ePORE® therapy Technology
    • ePORE® therapy Treats
    • Benefits of ePORE® therapy
    • EndoVE®
    • CUTIS
  • Skin Therapy
    • Clinicians
    • Patient Information
  • Gastrointestinal Therapy
    • Clinicians
    • Patient Information
  • News
  • References
  • Contact
Menu
  • About Mirai
  • Technology
    • What is Electroporation?
    • ePORE® therapy Technology
    • ePORE® therapy Treats
    • Benefits of ePORE® therapy
    • EndoVE®
    • CUTIS
  • Skin Therapy
    • Clinicians
    • Patient Information
  • Gastrointestinal Therapy
    • Clinicians
    • Patient Information
  • News
  • References
  • Contact

Author: admin

Filter by Topic
Galway-based Mirai Medical raises €3m in funding
Read More
25.03.2021
Endoscopic electrochemotherapy for Oesophageal cancer: a phase I clinical study
Read More
25.03.2021
Phase one Study on electrochemotherapy for colorectal cancer using endoscopic electroporation
Read More
25.03.2021

Contact Us

Twitter Linkedin-in Youtube
ePORE Therapy White Logo
Address:
Mirai Medical
Unit 5, Howley Court
Oranmore
Galway
Ireland
Email:
info@mirai-medical.com
Mirai Medical logo white
Dynamic Meta widget allowed only for Posts listing source or in Post context
Privacy & Cookies
ePORE® therapy, EndoVE® and CUTIS are approved for commercialisation in the European Union, United Kingdom and Australia. ePORE® therapy, EndoVE® and CUTIS are not cleared by FDA for commercialisation in the USA.
Website by Proactive Design & Marketing